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ABSTRACT 
Administering Dexamethasone Prior to Peripheral Nerve Blocks 
by Jacob Daniel Millwood 
December 2017 
Post-operative pain creates burdens for the patient and their family members 
while also drastically increasing the price of cost to the healthcare system. The Institute 
of Medicine Committee on Advancing Pain Research, Care, and Education states that the 
annual economic cost of chronic pain in adults is $560-630 billion (IOM, 2011). Regional 
anesthesia has been shown to provide potent analgesia that often times leads to a 
reduction in systemic analgesic requirements, opioid related side effects, general 
anesthesia requirements, and possibly the incidence of chronic post-operative pain. There 
are several adjunct medications that can be combined with peripheral nerve blocks to 
prolong the duration of action and provide longer periods of analgesia. Dexamethasone is 
a glucocorticoid that has been shown to increase the efficacy of peripheral nerve blocks 
during the post-operative phase of surgery when administered intravenously.  
An informal survey was performed at a hospital in the southeastern portion of the 
United States among anesthesia providers revealing that dexamethasone was not being 
administered when performing peripheral nerve blocks. A quality improvement 
educational project was performed from literature supporting the project. A pre-
intervention survey was implemented followed by the presentation. A post-intervention 
was then provided to the participating anesthesia providers and the results of the two 
surveys were then compared. The results showed an increase in the number of providers 
who administered dexamethasone intravenously prior to peripheral nerve blocks. A 
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majority of the participants stated that the intervention influenced their decision to 
administer intravenous dexamethasone when performing peripheral nerve blocks. 
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CHAPTER I - INTRODUCTION 
Background and Significance 
Approximately 75 million surgical procedures are performed in the United States 
each year. More than half of these procedures are performed in the inpatient setting 
(Macres, Moore, & Fishman, 2013). There have been many advances in the management 
of post-operative pain control but significant deficits continue to persist. The treatment of 
acute post-operative pain has still managed to be less than optimal (Macres, Moore, & 
Fishman, 2013). One of the major concerns in relation to general surgery is pain in the 
post-operative phase. Unrelieved pain can have detrimental effects on a patient’s physical 
and psychological well-being and can lead to a slower recovery time (Macres, Moore, & 
Fishman, 2013).  Some of the immediate consequences of severe acute pain includes 
reduced mobility, disturbed sleep patterns, dependence on pain relieving medications, 
and immune system impairment which increases a patient’s susceptibility to infection 
(Brennan et al., 2007). Pain is said to be a universal experience that is unique to each 
individual person. Research shows that poorly managed pain after surgery can produce a 
pathophysiologic process in both the peripheral nervous system and central nervous 
systems. This acute surgical pain has the potential to produce chronicity which can lead 
to long term negative consequences (Macres, Moore, & Fishman, 2013). In cases where 
chronic pain develops, a patient’s central nervous system can become hypersensitive. 
This increased sensitivity could lead to an increased pain response to where it would 
normally not be as painful (Institute of Medicine [IOM], 2011). 
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Problem Statement/Needs Assessment 
The economic cost of chronic pain in adults is $560-630 billion annually. This 
economic cost is according to a study done for the IOM Committee on Advancing Pain 
Research, Care, and Education (IOM, 2011). Post-operative pain creates burdens for the 
patient and their family members while also increasing costs to the healthcare system. 
Postoperative pain remains as a major problem in surgical patients. Pain that is 
experienced post-operatively is often masked by a patient’s acceptance of pain as a 
natural consequence of surgery (Macres, Moore, & Fishman, 2013). In a study released 
by the IOM, 80% of patients undergoing surgery experienced pain post-operatively. Of 
this 80%, fewer than half reported adequate pain relief. Furthermore, 10 to 50% of the 
patients with pain after surgery develop chronic pain. The development of chronic pain 
largely depends on the type of surgery the patient has undergone. It goes on to state that 2 
to 10% of these patients rate their chronic postoperative pain as severe (IOM, 2011). 
Inadequate pain relief after surgery may decrease patient satisfaction while increasing the 
length of hospital stay. Pain can delay surgical recovery, increase the cost of overall 
healthcare, and raise the risk of hospital readmissions (Patacsil, 2016).  
Acute pain is defined as “the normal, predicted, physiologic response to and 
adverse chemical, thermal, or mechanical stimulus.” (Macres, Moore, & Fishman, 2013. 
p.1612). The International Association for the Study of Pain (IASP) states that pain is an 
unpleasant sensory and emotional experience. It can be associated with actual or potential 
tissue damage (IASP, p. 209-214). The definition provided by this association recognizes 
the interplay between the objective, physiological sensory aspects of pain. It also 
recognizes the emotional, subjective, and psychological components of pain as well. The 
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response to pain among different individuals can be highly variable as well as in the same 
person just at different times (Rosenquist & Vrooman, 2013). In 2012, the American 
Society of Anesthesiologist (ASA) released an update to its Practice Guidelines for Acute 
Pain Management in the Perioperative Setting. In the updated report, the ASA strongly 
recommends the use of a multi-modal approach to pain management when possible 
(ASA, 2012). There has been an increase in support of the use of peripheral nerve blocks 
by anesthesia providers (Kirksey, Haskins, Cheng, & Liu, 2015). This rise in support may 
help to decrease the amount of pain that is experienced in the immediate post-operative 
phase of surgery (Patacsil, 2016).  
Acute post-operative pain is often times associated with a neuroendocrine 
response that is proportional to pain intensity and leads to the release of catecholamines 
from the adrenal medulla (Rosenquist & Vrooman, 2013). The release of catecholamines 
is a hormonal response that is a result of the increase in sympathetic tone. Moderate to 
severe pain can adversely affect the function of nearly every organ in the human body 
and may lead to negative perioperative outcomes such as myocardial ischemia, 
respiratory distress, constipation, and infection. These negative outcomes may adversely 
affect the perioperative morbidity and mortality rates (Rosenquist & Vrooman, 2013). 
The cardiovascular effects of pain are often times exhibited as hypertension, enhanced 
myocardial irritability, tachycardia, and an increase in systemic vascular resistance. 
These systemic effects can result in myocardial ischemia if it is not resolved due to an 
increase in oxygen demand and a decrease in the supply of oxygen (Rosenquist & 
Vrooman, 2013). Post-operative pain may also negatively affect the respiratory system 
when there is an increase in total body oxygen consumption and carbon dioxide 
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production that requires an increase in a patient’s respiratory rate. This rise in minute 
ventilation causes an increase in the work of breathing, especially in those patients with 
an underlying respiratory disease (Rosenquist & Vrooman, 2013). Pain may also 
negatively affect the gastrointestinal and urinary system by increasing sphincter tone, 
decreasing intestinal and urinary motility which promotes urinary retention (Rosenquist 
& Vrooman, 2015). The effects on the gastrointestinal tract are due to the physiological 
stress that pain places on the body and the increase in sympathetic tone (Rosenquist & 
Vrooman, 2013). The neuroendocrine stress response can depress the reticuloendothelial 
system which can predispose a patient to infection and may also enhance tumor growth 
and metastasis (Rosenquist & Vrooman, 2013). Lastly, pain can produce negative 
psychological effects such as sleep disturbances and anxiety, which are often times 
common reactions to acute post-operative pain. If this becomes a prolonged response, 
depression may develop. Unrelieved pain may lead to frustration and anger that can be 
directed at healthcare providers, family, and friends (Rosenquist & Vrooman, 2013). As 
mentioned earlier, there are many ways to treat and prevent post-operative pain. The 
widespread negative effects that pain has on the body post-operatively can prolong the 
recovery phase and must be treated appropriately. 
Regional anesthesia can provide potent analgesia that may lead to a reduction in 
the stress response that is often times exhibited with surgery. Peripheral nerve blocks are 
a form of regional anesthesia that can reduce systemic opioid requirements and their side 
effects, general anesthesia requirements, and possibly the incidence of chronic post-
operative pain. (Madison & IIfeld, 2015). Single-injection peripheral nerve blockade 
using local anesthetics has been shown to provide patients with pain control that is 
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superior to that of just opioids while leaving the patient with fewer side effects (Lin & 
Liu, 2013). 
The administration of local anesthetics blocks the conduction of impulses in 
electrically excitable tissues (Lin & Liu, 2013). One of the most important uses of 
peripheral nerve blocks is to provide analgesia and anesthesia by blocking the 
transmission of pain along the nerve fibers (Lin & Liu, 2013). Electrical impulses are 
conducted along nerve fibers as action potentials. An action potential is a brief, localized 
spike of positive charge along the nerve that is caused by a rapid influx of sodium ions 
down its electrochemical gradient. The flow of this sodium ion is mediated by a pump 
that is known as the voltage-gated sodium channel (Lin & Liu, 2013). 
Local anesthetics work by blocking the transmission of nerve impulses. This is 
achieved by targeting the function of voltage-gated sodium channels. Local anesthetics 
reversibly bind to the intra-cellular portion of the voltage-gated sodium channel, therefore 
inhibiting the action potential (Lin & Liu, 2013). Both the volume of the local anesthetic 
along with the concentration determine the degree of nerve blockade (Nagelhout & Plaus, 
2014). By blocking this action potential, the nerve is unable to perform its function which 
results in the inhibition of pain. 
Due to the increase in support of peripheral nerve blocks, there has been a 
decrease in the amount of pain that is experienced by the patient (Desmet, et al., 2013). 
Several adjunct medications can be added to local anesthetics when performing 
peripheral nerve blocks. These adjuncts often times allow for longer periods of pain relief 
post-operatively. The addition of dexamethasone intravenously prior to peripheral nerve 
blocks for the purpose of prolonging analgesia was the focus of this DNP project. The 
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administration of dexamethasone prior to peripheral nerve blocks has not been a common 
practice in the clinical sites that I have rotated through. Therefore, the goal for this DNP 
project is to gather and provide information in regards to dexamethasone and the effect 
that it has on post-operative pain relief in hopes of achieving a change of practice.  
Dexamethasone is metabolized in the liver via cytochrome P-450 enzymes. There 
have been no reports of adverse effects of a single injection of dexamethasone. But, 
patients who are sensitive to steroid administration, such as patients with diabetes, should 
be given the drug with caution. Steroids have the potential to increase blood glucose 
levels at larger doses (Nagelhout & Plaus, 2014). Another advantage related to the 
administration of dexamethasone besides the prolong duration of analgesia is that it has 
been found to be an effective treatment for the reduction of post-operative nausea and 
vomiting (Nagelhout & Plaus, 2014).  
Clinical Question 
The clinical question for this project was used to determine whether or not a 
change of practice has occurred. The question is: Are certified registered nurse 
anesthetists (CRNAs), who are provided evidence based research, willing to administer 
dexamethasone intravenously prior to performing peripheral nerve blocks in an attempt to 
prolong the duration of action of local anesthetics? The answer to this question will be 
determined by comparing a pre-intervention survey to a post-intervention survey after an 
evidence based presentation is provided. 
Recent studies show that potent glucocorticoid injections via the perineural route 
prolong the conduction block after peripheral nerve block application (Bailard, Ortiz & 
Flores, 2014). A large meta-analysis of the analgesic effects of intravenous 
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dexamethasone for postoperative pain indicated that this route was as effective in 
decreasing pain at rest, with movement, and opioid consumption (Bailard, Ortiz & Flores, 
2014). The duration of the blockade is associated with the potency of the glucocorticoid 
activity and appears to be steroid receptor dependent and locally mediated (Martinez & 
Fletcher. 2014). Dexamethasone is a glucocorticoid agonist that is often times generally 
indicated for its anti-inflammatory and anti-emetic effects. Dexamethasone has the ability 
to cross the cell membrane and binds to specific cytoplasmic receptors. This ability to 
cross cell membranes results in leukocyte infiltration interference at the site of 
inflammation and other inflammatory mediators are inhibited which leads to a reduction 
in edema or scar tissue while also suppressing the humoral immune response (Patacsil, 
2016). The anti-inflammatory actions of this particular drug are thought to involve the 
inhibition of phospholipase A2, lipocortins. These lipocortins are responsible for the 
control of the biosynthesis of potent mediators of inflammation such as prostaglandins 
and leukotrienes. Once this drug has crossed the lipid-bilayer, it binds in the cytoplasm 
with glucocorticoid receptors and moves into the nucleus (Patacsil, 2016). It has been 
demonstrated that corticosteroids inhibit signal transmission of nociceptive C-fibers, 
decrease ectopic neuronal discharge, and decrease the release of local inflammatory 
mediators (Patacsil, 2016). The inhibition of the pain signal decreases the perception of 
noxious stimuli from the periphery. 
Purpose of the Project 
The primary purpose of this DNP project was to propose a practice change to 
include the use of dexamethasone intravenously prior to performing a peripheral nerve 
block. The secondary goal of this DNP project was to improve postoperative outcomes in 
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surgical patients by providing longer periods of pain relief. Research shows that 
administering dexamethasone intravenously prior to peripheral nerve blocks will prolong 
the duration of sensory blockade and thus reduce the amount of post-operative pain that is 
experienced by the patient. This practice change was expected to improve patient 
satisfaction in the clinical setting, reduce hospital costs, and improve overall surgical 
experience as previously stated. According to a report from the IOM, pain continues to be 
a significant health problem that costs society at least $560-$635 billion annually (IOM, 
2011). While in the clinical setting, an informal poll was provided to practicing CRNAs, 
and it was determined that very few were aware of the effects of dexamethasone on 
peripheral nerve blocks when given the intravenous route. The main goal for this project 
was to educate anesthesia providers on the effectiveness of intravenous dexamethasone 
on peripheral nerve blocks and to encourage a change of practice as to where this 
becomes a mainstay in the way that peripheral nerve blocks are performed. Some benefits 
of this implementation is the improved physiological and psychological effects on the 
patient population, decreased recovery time post-operatively leading to a shorter hospital 
stay, decreased risk of hospital readmissions, and decreased overall healthcare costs. 
Evidence was provided via this project to encourage a practice change to include 
the use of intravenous dexamethasone when performing peripheral nerve blocks. A 
potential strength of this project is that hospital costs may be reduced due to the 
decreased recovery time that is experienced post-operatively. Patient satisfaction is 
improved due to lower incidences of post-operative pain as well as decreased occurrences 
of post-operative nausea and vomiting. A potential weakness of this type of project was 
that some anesthesia providers are unwilling to change the way that they administer 
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anesthesia due to the fact that they have had great success with the way that they have 
performed peripheral nerve blocks in the past. It is important that up to date evidence 
based practice is presented to clinical providers due to the ever changing healthcare 
setting. This new information will help to ensure that the best care can is provided to the 
patient population based off of the research that is available. 
Review of Literature 
The following section is a narrative review of literature concerning the use of 
intravenous dexamethasone to prolong the duration of action of local anesthetics when 
peripheral nerve blocks have been administered. The online databases used to search for 
articles related to the clinical question at hand were CINAHL, PubMed, and Google 
Scholar. The terms intravenous, dexamethasone, adjuncts, and peripheral nerve blocks 
were used interchangeably with results that were limited to within the last 10 years. A 
total 292 articles were found using the combination of these search terms. Five articles 
were chosen to be used exclusively for the literature review. Several scholastic anesthesia 
textbooks along with scholarly articles were utilized for the literature review in regards to 
this DNP project  
Some additives to local anesthetics can hasten the onset of nerve blocks, prolong 
block duration, or reduce toxicity (Bailard, Ortiz & Flores, 2014). A clinical review by 
Bailard, Ortiz, and Flores (2014) evaluated additives to local anesthetics for peripheral 
nerve blocks to gather evidence and determine limitations. The purpose of this review 
was to determine the clinical effectiveness and potential adverse effects of some common 
medications that are often times used in combination with local anesthetics for regional 
anesthesia. The clinical review compared the use of additive to local anesthetics for 
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peripheral nerve blocks and helped to establish evidence, limitations, and 
recommendations for the adjunct in question. One hundred and fifty patients undergoing 
interscalene brachial plexus block with ropivacaine hydrochloride for shoulder surgery 
were randomly assigned. The first group received a placebo, another group 10 mg of 
dexamethasone perineurally, and the third 10 mg dexamethasone intravenously. The 
results were established by determining the mean duration of analgesia after surgery. It 
was found that the administration of dexamethasone by either route nearly doubled the 
median duration of analgesia provided by the local anesthetic. The median duration of 
analgesia was found to be 1405 minutes when administered perineurally and 1275 
minutes when administered intravenously. The median time of analgesia was found to 
only be 757 minutes when dexamethasone was withheld and ropivacaine was the only 
drug administered. 
An interscalene brachial plexus block (ISB) is a type of peripheral nerve block 
that provides excellent analgesia for upper extremity surgery but it is time-limited 
(Desmet, et al., 2013). A comparison of intravenous and perineural dexamethasone 
administration when performing a single-shot interscalene block was examined by 
Desmet, et, al., (2013). The researchers stated that dexamethasone added to local 
anesthetics would prolong the duration of a single-shot ISB. A double-blind placebo-
controlled study was performed on patients that were undergoing an arthroscopic 
shoulder surgery. The subjects were then randomly separated into three different groups. 
The first group received ropivacaine 0.5% alone. The second group received ropivacaine 
0.5% and dexamethasone 10 mg along with the local anesthetic. The final group received 
ropivacaine 0.5% with intravenous dexamethasone at 10 mg. The duration of analgesia, 
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which was defined as the time between the administration of the block and the first 
analgesic request, was the primary outcome that was measured. One hundred and fifty 
patients were included in the study after an ethical committee approval was obtained 
along with patient informed consent. There was a significant difference between those 
that received just ropivacaine which had a duration of action of 757 minutes compared to 
the dexamethasone groups which had a mean duration of 1405 (perineurally) and 1275 
(intravenously) (p = 0.0001). The study concluded with stating that due to the fact that 
dexamethasone is not FDA approved for perineural use, clinicians should consider 
administering dexamethasone intravenously as opposed to perineurally. This route of 
administration is due to its equivalency when compared to perineural administration to 
achieve an increase in duration of ISB (Desmet et al., 2013).  
A recent large meta-analysis, performed by De Oliveira, Almeida, Benzon, and 
McCarthy (2011), of the analgesic effect of intravenous single-dose dexamethasone for 
post-operative pain indicated that doses of greater than 0.1 mg/kg are effective in 
decreasing pain and opioid consumption. It is possible that some of the analgesia-
prolonging effect of perineural dexamethasone could be achieved by intravenous 
administration (De Oliveira, Almeida, Benzon & McCarthy, 2011). Three groups were 
divided up in this study to determine the effects of dexamethasone at different dosages. 
There was a low dose group which received less than 0.1 mg/kg. There was an 
intermediate group which received 0.11-0.2 mg/kg and lastly a high dose group that 
received > 0.21 mg/kg. The authors stated that the mean combined effects favored 
dexamethasone over placebo for pain at rest and with movement. It was noted that 
opioid consumption was decreased to a similar extent with moderate and high doses of 
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the dexamethasone. Opioid consumption was not decreased with the low-dose 
dexamethasone administration in this study. Furthermore, it was determined that there 
was no increase in effectiveness between the high dose and intermediate dose of 
dexamethasone. The administration of dexamethasone in the pre-operative phase 
appears to be more effective when compared to the administration of this drug in the 
intra-operative phase. The authors concluded that dexamethasone at doses of 0.1 mg/kg 
or greater is an effective drug in reducing postoperative pain and opioid consumption 
after surgery. The preoperative administration of the drug worked more effectively and 
produced less variation in pain control outcomes. The meta-analysis revealed that an 
intermediate-dose of dexamethasone reduced the amount of opioids needed post-
operatively to reduce pain. High dose dexamethasone administration had opioid sparing 
effects while also decreasing pain scores which can be attributed to its analgesic 
properties. 
Dexamethasone has been shown to have powerful anti-inflammatory action and 
has demonstrated the ability to reduce morbidity after surgery (Hong, Han, Kim, E., 
Kim, J. & Kil, 2010). A study by Hong, et al., (2010) was performed to determine and 
examine the effects of a single dose of intravenous dexamethasone in combination with 
a caudal block on postoperative analgesia in children. Seventy-seven children between 
the ages of 1-5 years old undergoing an orchiopexy procedure were included in this 
study. The two different groups of children either received dexamethasone at 0.5 mg/kg 
or the same volume of saline before a caudal anesthetic block was performed. The 
caudal was performed using 1.5 mL/kg of ropivacaine 0.15% in all of the patients. Pain 
scores, analgesic consumption, and adverse effects were all evaluated for the first 24 
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hours following surgery. The authors stated that fewer patients in the dexamethasone 
group required opioids for analgesia in the post anesthesia care unit. The results of this 
study showed that only 7.9% of the patients that received dexamethasone required 
fentanyl for analgesia. Of the patients who did not receive dexamethasone with their 
block, 38.5% required additional fentanyl for pain relief. The time to the first 
administration of acetaminophen was significantly longer in the dexamethasone group 
(646 minutes versus 430 minutes) showing that those who received dexamethasone with 
their peripheral nerve block had longer periods of pain relief. The postoperative pain 
score was lower in the group of children who received dexamethasone prior to the 
regional block. In conclusion, intravenous dexamethasone at 0.5 mg/kg in combination 
with a caudal block augments the duration and intensity of the postoperative analgesia 
that is experienced by children. 
A trial determining the effects of intravenous dexamethasone and perineural 
dexamethasone was performed by Abdallah, Johnson, Murgatroyd, Ghafari, Ami, Jin and 
Brull (2015). This study determined how the two routes similarly prolonged the duration 
of analgesia after a supraclavicular brachial plexus block was performed. The ultimate 
purpose of this study was to confirm that the addition of intravenous dexamethasone 
would prolong the duration of analgesia after a single-shot injection supraclavicular block 
was performed. They compared the intravenous administration of dexamethasone with 
the conventional local anesthetic alone or in combination with perineural dexamethasone 
for surgeries on the upper extremity of patients. In this study, 75 patients who were 
receiving a supraclavicular block were placed randomly into three different groups. The 
first group received 30 mL of 0.5% bupivacaine alone, the second group received 
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intravenous dexamethasone at a dose of 8mg, and the third group received perineural 
dexamethasone at 8 mg. Pain scores, opioid consumption, motor block duration, patient 
satisfaction, and block related complications were all analyzed for this study. The 
duration of analgesia was prolonged in the intravenous group when compared to the 
control group but similar to the group that received dexamethasone perineurally. It was 
determined that the duration of analgesia was prolonged in the group that received 
intravenous dexamethasone and perineural dexamethasone (25 hours) compared to the 
group that just received bupivacaine (13.2 hours). The intravenous and perineural 
dexamethasone groups both had reduced pain scores, improved satisfaction, and reduced 
postoperative pain control in comparison to the local anesthetic alone group. The 
researchers stated that with a supraclavicular block, the effectiveness of intravenous 
dexamethasone in prolonging the duration of analgesia seems to be very similar to that of 
perineural dexamethasone administration (Abdallah, et al., 2015). This conclusion is a 
significant finding for this DNP project due to the equivalency of action that intravenous 
dexamethasone shows when compared to that of perineural dexamethasone.  
Conclusion 
The treatment of acute post-operative pain is still less than optimal (Macres, 
Moore, & Fishman, 2013). Some of the immediate consequences of severe acute pain 
include loss of strength, reduced mobility, a disruption in sleep patterns, immune system 
impairment which could increase susceptibility to disease and infection, and dependence 
on opioids (Brennan et al., 2007). Due to the increasing use of peripheral nerve blocks, it 
is important to continue research and education in this area of health care to promote 
better patient outcomes and improve overall surgical satisfaction. From the literature 
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review, it was determined that dexamethasone, when administered intravenously prior to 
performing peripheral nerve blocks, was effective at prolonging the period of analgesia 
post-operatively. 
Doctor of Nursing Practice Essentials 
 The DNP essentials that were incorporated in this project can be found in 
Appendix F. All essentials were met upon completion of this project and a brief 
explanation of each is provided in the table. Emphasis was placed on essential I, II, and 
VIII which were most closely related to this project 
Theoretical Framework 
There has been a tremendous increase in the amount of clinical based research 
and its contribution to evidence based practice. The accessibility to this research has been 
made extremely easy due to the advancements of technology. Despite the advancement of 
technology, practitioners continue to have difficulty implementing the latest evidence 
based research and integrating it into practice (Rosswurm & Larrabee, 1999). The 
Nursing Intellectual Capital Theory was chosen as a basis for this DNP project. This 
theory states that the nursing structural capital is directly related to the quality of care in 
the healthcare setting. The theory of nursing intellectual capital proposes nurses’ 
knowledge, experience, and skills are related to patient outcomes. These outcomes are 
often times associated with the quality of care that is provided in the healthcare setting. It 
is also associated with the organizational outcomes in relation to recruitment and 
retention of nurses (Covell & Sidani, 2013).  
Nursing intellectual capital is defined as the knowledge translated into 
organizational and personnel performance (Covell & Sidani, 2013). The goal was to 
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implement the latest evidence based research into practice by administering intravenous 
dexamethasone prior to peripheral nerve blocks in an attempt to prolong the duration of 
pain relief. Nursing performance can lead to improvements in patient outcomes 
associated with quality of patient care (Covell & Sidani, 2013). The results of the 
implementation of this suggested a change of practice could possibly lead to a decrease in 
adverse events in the perioperative setting. This change of practice would mean a 
decrease in the amount of postoperative pain that is experienced, which may result in an 
increase in patient satisfaction and well-being and a decrease in hospital length of stay. 
The purpose of organizational performance was to improve organizational outcomes. 
These are the cost-related outcomes associated with retention of knowledge and the 
recruitment of experienced nurses (Covell & Sidani, 2013). Nursing human capital is 
defined as the knowledge, skills, and experience of nurses. Through continued education, 
the goal of this doctoral project was to propose a practice change for the usage of 
dexamethasone intravenously prior to peripheral nerve blocks. This type of nursing 
capital was implemented by the anesthesia providers at a level 2 hospital in the 
southeastern United States. Nursing structural capital are the resources which contain 
nursing knowledge. This capital is used to support registered nurses in the application of 
their knowledge in the clinical setting. It is also attributed to the skills they provide to 
healthcare consumers. This type of capital can be structured as practice guidelines and 
information technology for diagnostic purposes (Covell & Sidani, 2013). The research 
gathered for this project was presented to the anesthesia providers. The research that was 
presented could lead to the creation of a protocol or practice guideline to create structural 
capital in the healthcare environment. Nurse staffing is defined as the supply and the mix 
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of nurses who possess the knowledge, skills, and experience to competently meet the care 
needs of patients on the unit (Covell & Sidani, 2013). 
Summary 
The implementation of the latest evidence based research directly effects the 
quality of care that is provided in the healthcare setting. The nursing intellectual theory 
that was chosen for this project directly relates how the latest research can influence the 
way that healthcare is practiced. By implementing the nursing intellectual capital theory, 
there was an increase in the quality of care that was provided by improving nurses’ 
knowledge, skills, and experience. 
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CHAPTER II – METHODOLOGY 
Overview 
The purpose of this doctoral project was to encourage a practice change of 
anesthesia providers implementing the administration of dexamethasone intravenously 
prior to performing peripheral nerve blocks to prolong the duration of action of the local 
anesthetic and provide longer periods of analgesia. The literature review helped establish 
the importance of postoperative pain relief and the benefits of administering 
dexamethasone when performing peripheral nerve blocks. The primary goal of this 
doctoral project was to provide evidence-based research to anesthesia providers in order 
to encourage a change of practice. Improving patient outcomes by administering 
dexamethasone intravenously along with peripheral nerve blocks fulfilled the secondary 
goal of this doctoral project. This improvement came at minimal increased effort to the 
practitioner due to the fact that dexamethasone is often times given at the beginning of 
procedures for the anti-emetic qualities that it possesses. Wang, Ho, Tzeng and Tang 
(2000) found that dexamethasone, when given prior to the induction of anesthesia was 
more effective at preventing nausea and vomiting than when administered in the post-
operative or intra-operative phase of surgery. 
Target Population 
The participants for this doctoral project were are all anesthesia providers 
employed at a 512 bed inpatient facility in the southeastern portion of the United States. 
This facility offers a wide range of surgical services that include: neurosurgery, 
cardiothoracic, general, obstetrics, trauma, ear/nose/throat, orthopedic, and 
reconstructive. The inclusion criteria for participants are anesthesia providers who are 
 19 
licensed and certified at this facility. The participants of this project were either full-time 
or part-time employees when the intervention is being conducted. There was no random 
selection among the participants. Exclusion criteria included anesthesia providers who do 
not perform peripheral nerve blocks, surgeons, and any other employee of the facility 
who does not directly administer anesthesia. Those providers who chose not to participate 
were also excluded from the project. 
Protection of Human Subjects 
Institutional Review Board (IRB) approval was obtained from The University of 
Southern Mississippi (Protocol number 17080302) and the participating facility’s 
Nursing Research Council. The committee chair, committee members, and the author of 
the project had completed the required CITI Common Course Training module. 
Participants in this DNP project were kept anonymous by allowing the participants to 
choose whether or not they wanted to participate in the project. The data collection 
process was completed 2 weeks after the initial evidence based presentation was 
provided. A lock box was left at the facility in order for the participants to return their 
completed post-presentation surveys. The key to this lock box was kept in a secure place 
where only the author of this project had access. All data collected from this project will 
be deleted and/or shredded 6 months after all graduation requirements are met and 
completed. All participants maintained anonymity and were able to decide whether or not 
they choose to partake in the project. There were several potential benefits to this DNP 
project which included a possible increase in patient safety, decreased financial burden 
on the patient and facility, and improved patient satisfaction. There were no physiologic 
or psychological threats associated with this quality improvement project. 
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Design of Measurement Tools 
A quality improvement educational presentation was held for the participating 
anesthesia providers at the chosen facility during operational hours. The evidence-based 
presentation was compiled from scholastic anesthesia textbooks as well as the literature 
review. The participating anesthesia providers were asked to complete a survey prior to 
the presentation (Appendix A). This survey was used to assess whether or not the 
participating anesthesia providers use dexamethasone in conjunction with peripheral 
nerve block administration. If they currently did so, it was then determined whether or 
not it is administered before, during, or after performing the block. It was also determined 
through this survey whether or not they administer dexamethasone intravenously or 
perineurally. Barriers to implementation and the frequency in which they perform 
peripheral nerve blocks were also determined. The survey was also used to determine the 
age, and gender of the participant as well as the length of time they have been practicing. 
The participants were informed that they were providing consent to participate in the 
doctoral project by filling out the questionnaire. Surveys were collected and the data was 
analyzed using descriptive statistics. 
After 2 weeks elapsed, another survey was given to the anesthesia providers that 
chose to participate in the DNP project (Appendix B). This survey was used to determine 
whether or not the anesthesia providers administered intravenous dexamethasone prior to 
the peripheral nerve blocks that they performed after the evidence-based presentation was 
provided to them. It was also determined whether or not the evidence-based presentation 
influenced their willingness to administer dexamethasone when performing peripheral 
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nerve blocks. Descriptive statistics was used to compare the results of the initial survey 
and the second survey to determine if anesthesia providers changed their practice. 
Assumptions 
An assumption of this project was that post-operative pain control needed to be 
improved upon in the hospital setting. Another assumption of the project was that the 
anesthesia providers at this facility were not currently up to date on the latest literature in 
regards to the administration of dexamethasone intravenously prior to peripheral nerve 
blocks. The final assumption of this project was the willingness of the current anesthesia 
providers to participate. 
Resource Requirements 
A location in the southeastern portion of the United States was needed for the 
project as well as anesthesia staff to participate in the project. The physical resources 
needed for this included paper and ink for the pre and post questionnaires. A data 
collection lock box was needed for the post presentation questionnaires to be returned. 
The availability of dexamethasone, local anesthetics, and peripheral nerve block 
administration equipment was also needed.  
Summary 
Implementing the administration of intravenous dexamethasone prior to 
peripheral nerve blocks required the participation of anesthesia providers as well as 
different physical resources. These physical resources were readily available at the 
chosen facility. The anesthesia providers who chose to participate in the project were also 
available the day of the intervention. After the evidence based presentation was provided 
to the providers and the 2-week data collection process was completed, descriptive 
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statistics was used to determine if the participating anesthesia providers began to 
administer dexamethasone intravenously prior to performing peripheral nerve blocks. 
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CHAPTER III  - RESULTS 
Overview 
On the day of the presentation, a pre-intervention questionnaire was given to 
anesthesia providers. This survey was used to gather demographic information on the 
anesthesia providers and it was also used to determine whether or not dexamethasone was 
being administered along with their peripheral nerve blocks. Upon completion of the 
survey, an evidence-based presentation was then provided via a power point presentation. 
After completion of the presentation, the anesthesia providers were then informed of the 
data collection box that would be used to return a second survey after 2 weeks had 
elapsed. Upon completion of the two-week data collection period, the surveys were then 
collected and stored in a secure location that only the author had access to. The post-
intervention survey was used to assess whether or not anesthesia providers began 
administering dexamethasone intravenously prior to peripheral nerve blocks based on the 
presentation that was provided on the day of the intervention. 
Statistical Analysis of Data 
The primary goal of this project was to propose a practice change to where 
dexamethasone would be administered intravenously prior to performing peripheral nerve 
blocks in order to prolong the period of analgesia for patients undergoing surgery. There 
were seven anesthesia providers who participated in the presentation and filled out the 
pre-intervention survey. Descriptive statistics were then used to describe the participants 
of the project and a frequency count was then used to determine if a practice change had 
occurred over the two-week data collection period. All seven of the participants in the 
project were males whose ages ranged between 31 and 59. The years of experience in 
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practicing anesthesia ranged between 1 and 33. The number of peripheral nerve blocks 
performed by the participating anesthesia providers ranged from 4 to 20 per month. 
According to the pre-intervention survey, four of the seven participants administered 
dexamethasone. Of these four, two of the participants were administering dexamethasone 
perineurally and the other two were using both the intravenous and perineural route. The 
other three participants indicated that they were not administering dexamethasone when 
performing peripheral nerve blocks. 
Of the seven participants who completed the pre-intervention survey, six of them 
completed the post-intervention survey once the 2 weeks of the data collection process 
had ended. Five out of the six participants revealed that the evidence-based intervention 
influenced their decision to administer dexamethasone intravenously when performing 
peripheral nerve blocks. One of the participants denoted that he still does not administer 
dexamethasone when performing peripheral nerve blocks. Of the five participants who 
administer dexamethasone with peripheral nerve blocks, three of them indicated they 
administer the drug both the perineural and intravenous route while the other two 
indicated they began administering the drug intravenously. 
Summary 
It was determined that a change of practice had occurred due to the results of the 
post-intervention survey. The administration of dexamethasone intravenously was being 
implemented by a majority of the participants in the project. The change of practice that 
occurred at this facility could potentially improve the quality of care provided based on of 
the information that was provided. 
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CHAPTER IV – DISCUSSION 
Implications 
As a result of the intervention, there was an increase in the administration of 
dexamethasone prior to peripheral nerve blocks via the intravenous route. Five 
participants revealed they utilized dexamethasone when performing peripheral nerve 
blocks. A majority of the participants in the project began utilizing dexamethasone 
intravenously when performing peripheral nerve blocks. Only one of the six participants 
who returned the post intervention survey revealed he did not begin implementing the use 
of dexamethasone with nerve blocks. As a result of the DNP project, a change of practice 
did occur as evidenced by the results of the post-intervention survey. Five out of the six 
participants denoted the evidence-based presentation influenced their decision to begin 
administering dexamethasone intravenously when performing peripheral nerve blocks. 
Limitations and Barriers 
A limitation to this study was the small sample size from which the data 
collection was obtained. There were also limited responses to the project, which made it 
more difficult to draw conclusions from the information that was provided. Also, the 
reduced data collection time period was a limitation to the study and the results. There 
were only a limited number of peripheral nerve blocks that could be performed in the 2-
week data collection process. 
Recommendations 
Quality improvement educational projects regarding this topic would be 
beneficial for the facility in which the project took place. A larger sample size along with 
a longer data collection window would allow for results that could provide greater detail 
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about whether or not there is an interest in a proposed change of practice. Presenting the 
data over a longer period could have potentially led to an increase in the implementation 
of dexamethasone intravenously prior to peripheral nerve blocks. 
Conclusion 
After the intervention, there was an increase in the number of providers who 
administered dexamethasone intravenously when performing peripheral nerve blocks. 
Literature supports the administration of dexamethasone intravenously prior to 
performing peripheral nerve blocks in order to prolong the period of analgesia. The goal 
of this study was to propose a practice change in order to decrease the amount of pain 
that is experienced in the post-operative phase of surgery. This change of practice would 
improve the quality of care provided to patients, which in turn would increase patient 
satisfaction while lowering hospital costs. 
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APPENDIX A – Pre-Intervention Survey 
Pre-Intervention Survey 
By agreeing to fill out this survey you are consenting to participate in this project. You 
are not required to participate and may withdraw at any time without penalty. If you have 
any questions you may contact me (Jacob.millwood@usm.edu) or Dr. Marjorie-Everson 
(Marjorie.geiszeverson@usm.edu). 
1) What is your age? 
       ________ 
2) What is your gender? 
a. Male 
b. Female 
3) How many years have you been practicing anesthesia? 
 ________ 
4) How often do you administer peripheral nerve blocks in a month? 
 _________ 
5) Do you currently administer dexamethasone in conjunction with your peripheral 
nerve blocks? 
a. Yes 
b. No 
6) If you currently administer dexamethasone for nerve blocks, which route is 
chosen? 
a. Perineurally 
b. Intravenously 
7) If you answered yes to administering dexamethasone, when do you administer it 
in relation to the the nerve block? 
a. Before 
b. During  
c. After 
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APPENDIX B – Post-Intervention Survey 
Post Intervention Survey 
 By agreeing to fill out this survey you are consenting to participate in this project. You 
are not required to participate and may withdraw at any time without penalty. If you have 
any questions you may contact me (Jacob.millwood@usm.edu) or Dr. Marjorie-Everson 
(Marjorie.geiszeverson@usm.edu). 
1) What is your age range? 
 ________  
2) What is your gender? 
a. Male 
b. Female 
3) How many years have you been practicing anesthesia? 
 _________ 
4) How often do you administer peripheral nerve blocks in a month? 
_________ 
5) Do you currently administer dexamethasone in conjunction with your peripheral 
nerve blocks? 
a. Yes 
b. No 
6) If you currently administer dexamethasone for nerve blocks, which route is 
chosen? 
a. Perineurally 
b. Intravenously 
7) If you answered yes to administering dexamethasone, when do you administer it 
in relation to the the nerve block? 
a. Before 
b. During  
c. After 
8) Did the evidence-based presentation influence your decision to administer 
dexamethasone intravenously prior to performing peripheral nerve blocks? 
a. Yes 
b. No 
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APPENDIX C – IRB Approval Letter 
 
 
INSTITUTIONAL REVIEW BOARD  
118 College Drive #5147 | Hattiesburg, MS 39406-0001 Phone: 601.266.5997 | Fax: 601.266.4377 | 
www.usm.edu/research/institutional.review.board  
NOTICE OF COMMITTEE ACTION  
The project has been reviewed by The University of Southern Mississippi Institutional Review 
Board in accordance with Federal Drug Administration regulations (21 CFR 26, 111), Department 
of Health and Human Services (45 CFR Part 46), and university guidelines to ensure adherence 
to the following criteria:  
• The risks to subjects are minimized.  
• The risks to subjects are reasonable in relation to the anticipated benefits.   
• The selection of subjects is equitable.   
• Informed consent is adequate and appropriately documented.   
• Where appropriate, the research plan makes adequate provisions for monitoring the data collected to 
ensure the safety of the subjects.   
• Where appropriate, there are adequate provisions to protect the privacy of subjects and to  maintain the 
confidentiality of all data.   
• Appropriate additional safeguards have been included to protect vulnerable subjects. 
• Any unanticipated, serious, or continuing problems encountered regarding risks to subjects must  be 
reported immediately, but not later than 10 days following the event. This should be reported  to the IRB 
Office via the “Adverse Effect Report Form”. 
• If approved, the maximum period of approval is limited to twelve months.  Projects that exceed this period 
must submit an application for renewal or continuation.   
PROTOCOL NUMBER: 17080302 
PROJECT TITLE: Administering Dexamethasone Intravenously Prior to Performing Peripheral Nerve Blocks 
PROJECT TYPE: New Project 
RESEARCHER(S): Jacob Daniel Millwood 
COLLEGE/DIVISION: College of Nursing 
DEPARTMENT: Advanced Practice 
IRB COMMITTEE ACTION: Exempt Review Approval 
PERIOD OF APPROVAL: 08/07/2017 to 08/06/2018  
Lawrence A. Hosman, Ph.D. Institutional Review Board  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APPENDIX D – Letter of Agreement 
RESEARCH PROPOSAL LETTER OF AGREEMENT 
TO: Jacob Millwood  
FROM:   Research Committee 
RE:  Proposed project/study entitled: Administering Dexamethasone 
Intravenously Prior to Performing Peripheral Nerve Blocks 
 
On August 8, 2017 your research project/study proposal was approved by the Nurse 
Practice Council to be conducted within Patient Care Services at 
. You are free to proceed with your project/study within the following guidelines: 
 
1. You are required to complete an online non-employee orientation that is administered 
though our Education Department (601-288-2677). 
2. A Non-Employee Confidentiality and Nondisclosure Agreement must be signed during the online 
orientation process. 
3. Any modifications to this approved study must be re-routed to the Research Committee.  All 
activity on this project must stop until you are notified by the Research Committee Chair of 
Committee’s decision regarding proposed changes 
4. Data Collection Period:  
5. Inform Research Chair when data collection is initiated and when completed (via e-mail) 
6. Provide results of study to committee (may provide presentation or written documentation 
of findings)  
 
Sincerely, 
 
 
 
 
 
I, ___, have reviewed the above guidelines and 
agree to comply with the terms of this Research Proposal Letter of Agreement. 
 
Signature: ___ __Date: _8/16/2017__ 
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APPENDIX E – Letter of Support 
Letter of Support 
July 5, 2017 
I, Joe Campbell, MD ,support Jacob Millwood’s DNP project to propose a practice 
change to implement the administration of dexamethasone intravenously prior to 
performing peripheral nerve blocks. 
 
 
 
 
 
Sincerely, 
 
 
 
 
Dr. Joe Campbell 
 
  
 32 
APPENDIX F –DNP Essentials 
• Essential 1: Scientific Underpinnings for Practice 
• This DNP project describes strategies that encourage a change of practice that in 
turn help to decrease post-operative pain which can lead to an increase in patient 
satisfaction and outcomes. 
• The latest evidence based research was gathered to further improve the 
healthcare environment and improve patient safety. 
• Essential 2: Organizational and Systems Leadership for Quality 
Improvement and Systems Thinking 
• This DNP project evaluates a care delivery system through the administration of 
dexamethasone intravenously prior to peripheral nerve blocks to prolong the 
duration of action of the local anesthetic to improve patient outcomes for the 
undergoing surgery. 
• Improving patient outcomes by demonstrating strong leadership skills is a part of 
the foundation of this research project. 
• Essential 3: Clinical Scholarship and Analytical Methods for Evidence-Based 
Practice 
• This DNP project used analytical methods to appraise existing research of the 
effects of administering dexamethasone to reduce post-operative pain.  
• An in-service was developed in an attempt to educate practicing anesthesia 
providers for the improvement of post-operative pain control through the 
administration of dexamethasone intravenously prior to peripheral nerve blocks. 
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• Essential 4: Information Systems/Technology and Patient Care Technology 
for the Improvement and Transformation of Health Care.  
• This DNP project demonstrates an effective ability to implement and execute an 
evaluation plan for the use of dexamethasone and peripheral nerve blocks by 
anesthesia providers. 
• Electronic databases were used to allocate evidence-based research for the 
administration of intravenous dexamethasone and the role that this plays on 
peripheral nerve block prolongation. 
• Essential 5: Health Care Policy for Advocacy in Health Care 
• This DNP project may improve healthcare related outcomes for patients that are 
receiving peripheral nerve blocks by developing, evaluating, and providing 
leadership to encourage a change in the way providers practice. 
• Knowledge of advanced practice nursing will be exemplified through implementing 
the change of practice to improve patient outcomes and safety. 
• Essential 6: Inter-professional Collaboration for Improving Patient and 
Population Health Outcomes 
• This DNP project utilized therapeutic communication and collaborative skills 
among the different anesthesia providers to develop and implement a change in 
health care. 
• Essential 7: Clinical Prevention and Population Health for Improving 
Nation’s Health 
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• This DNP project disseminated clinical findings in regards to dexamethasone 
administration prior to peripheral nerve blocks to practicing anesthesia 
providers to improve overall outcomes and prevent post-operative pain 
• The findings will have the potential to decrease post-operative pain and improve 
the health and satisfaction of surgical patients. 
• Essential 8: Advanced Nursing Practice 
• This DNP project designed, implemented, and evaluated whether or not a 
practice change occurred in response to the evidence based research that was 
presented to the practicing anesthesia providers. 
• The research that was gathered for this project will further educate practicing 
anesthesia providers on the current data that is available. 
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